Efficacy and safety of combination PD‐1/PD‐L1 checkpoint inhibitors for malignant solid tumours: A systematic review

Lignende værker

• The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/PD-L1 plus anti-CTLA-4): a systematic review and meta-analysis
  af: Gu, Lihu, et al.
  Udgivet: (2019)
• Safety and efficacy of PD-1/PD-L1 immune checkpoint inhibitors in patients with pre-treated advanced stage malignant mesothelioma: a systematic review and meta-analysis
  af: Amjad Zafar, et al.
  Udgivet: (2024-11-01)
• Clinical utility of tumour mutational burden on efficacy of immune checkpoint inhibitors in malignant solid tumours: protocol for a systematic review and meta-analysis
  af: Xiaoguang Yang, et al.
  Udgivet: (2022-08-01)
• Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer
  af: Wu, Bogang, et al.
  Udgivet: (2018)
• A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer
  af: Fan, Zhongyuan, et al.
  Udgivet: (2019)